| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Core Laboratories Inc. /DE/ | Director | Common Stock | 41,962 | $628,591 | $14.98 | 01 Apr 2025 | Direct |
| CORE LABORATORIES N V | Director | Common Shares | 26,226 | 01 Apr 2023 | Direct | ||
| Core Laboratories Inc. /DE/ | Director | Restricted Shares | 0 | 01 Apr 2025 | Direct | ||
| CORE LABORATORIES N V | Director | Restricted Shares | 0 | 01 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLB | Core Laboratories Inc. /DE/ | 01 Apr 2025 | 3 | $0 | 4 | Director | 02 Apr 2025, 14:37 |
| CLB | Core Laboratories Inc. /DE/ | 01 Apr 2024 | 3 | $0 | 4 | Director | 02 Apr 2024, 17:05 |
| /report/000120919123022048-klingensmith-harvey-robert-2023-04-01 | CORE LABORATORIES N V | 01 Apr 2023 | 3 | $0 | 4 | Director | 03 Apr 2023, 13:36 |
| /report/000120919122022510-klingensmith-harvey-robert-2022-04-01 | CORE LABORATORIES N V | 01 Apr 2022 | 3 | $0 | 4 | Director | 04 Apr 2022, 17:05 |